An association between pathogenic heterozygous ATM variants and cancer susceptibility was first noted for breast cancer (MIM #114480), when a moderately increased risk was demonstrated for carrier women, first in Ataxia-Telangiectasia families [7], then in the general population [23, 24]. This evidence concerns the gene ATM and ataxia telangiectasia.